Cantor Fitzgerald Reaffirms “Overweight” Rating for Ardelyx (NASDAQ:ARDX)

Ardelyx (NASDAQ:ARDX – Get Free Report)‘s stock had its “overweight” rating reiterated by research analysts at Cantor Fitzgerald in a research report issued on Thursday, Benzinga reports. ARDX has been the subject of a number of other reports. Wedbush reiterated an “outperform” rating and issued a $15.00 price target on shares of Ardelyx in a […]

Leave a Reply

Your email address will not be published.

Previous post EyePoint Pharmaceuticals (NASDAQ:EYPT) Earns “Overweight” Rating from Cantor Fitzgerald
Next post Adams Asset Advisors LLC Sells 148 Shares of Cummins Inc. (NYSE:CMI)